GNC

Melatonin 3

C+
N+ Score74
Sleep & RecoveryServing: 1 Tablet(s)Type: Other Combinations

GNC Melatonin 3 is a sleep and recovery supplement featuring a simple blend of two ingredients. It has an N+ Score of 74, earning a C+ grade, indicating a good quality product for its specific purpose. The product provides 3 mg of Melatonin, a dosage commonly used to help regulate sleep cycles, alongside 2 mg of Vitamin B6, which is present at a clinically studied dose and may support nervous system function. The minimalist formulation offers clear transparency regarding its active components. This supplement is ideal for individuals seeking direct support for sleep onset and regulation with a straightforward ingredient profile.

About This Product

Melatonin 3 by GNC is a sleep & recovery supplement containing 2 active ingredients. It has earned an N+ Score of 74/100 (Grade C+).

This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.

Notable clinical-dose ingredients include Vitamin B6.

N+ Score Breakdown

Ingredient Adequacy100/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity65/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Key ingredients at clinically effective doses
  • +Fully transparent label with individual ingredient amounts disclosed
  • +1 ingredient(s) at clinical dose levels

Weaknesses

  • −Missing several expected ingredients for its category

Ingredient Analysis (2 ingredients)

IngredientAmountDose Adequacy
Vitamin B62.000 mgOptimal
Melatonin3.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.